Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585103 · ClinicalTrials.gov registry record · NA
Cytosponge Protocol IRB 11-006429
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT01585103: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT01585103 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01585103, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
This study is being done to collect data on the potential use of the cytosponge as non-invasive tool in evaluating patients with eosinophilic esophagitis.
Interventions
- DEVICE Cytosponge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01585103
The ClinicalTrials.gov registry entry for NCT01585103 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cytosponge is the first listed.
NCT01585103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01585103 about?
NCT01585103 is a clinical study titled "Cytosponge Protocol IRB 11-006429". This study is being done to collect data on the potential use of the cytosponge as non-invasive tool in evaluating patients with eosinophilic esophagitis.
What is the current status of trial NCT01585103?
This trial is currently terminated. It is a NA study. The enrollment target is 86 participants. The study started on 2012-12. Estimated completion is 2016-06-07.
What interventions are being tested in trial NCT01585103?
The interventions under investigation include: Cytosponge (DEVICE).
Who is sponsoring clinical trial NCT01585103?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.